US Broker Ratings

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 10% Potential Upside in Healthcare Plans

Alignment Healthcare, Inc. (ALHC) is gaining attention in the healthcare sector, particularly for its focus on transforming senior healthcare through innovative Medicare Advantage plans. Headquartered in Orange, California, the company..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 71.99% Potential Upside

Surgery Partners, Inc. (NASDAQ: SGRY) is making waves in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.91 billion, the company holds a..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a 44.9% Potential Upside Amidst Healthcare Innovations

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, stands at the forefront of innovation in the field of targeted therapeutics and immunotherapies. Specializing in the treatment of..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Assessing a Potential 97.3% Upside for Biotechnology Investors

Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, is drawing significant attention from investors due to a compelling potential upside of 97.3%. Headquartered in Suzhou, China,..

Neogen Corporation (NEOG) Stock Analysis: Healthcare Diagnostics Firm with 13.82% Upside Potential

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, is drawing investor attention with its impressive potential upside of 13.82%. Operating primarily in..

Addus HomeCare Corporation (ADUS) Investor Outlook: A 33.88% Potential Upside Beckons

Investors eyeing opportunities in the healthcare sector might find Addus HomeCare Corporation (ADUS) an appealing prospect. With a focus on providing comprehensive personal care, hospice, and home health services, the..

Teladoc Health, Inc. (TDOC) Investor Outlook: Is the 66% Upside Within Reach?

Teladoc Health, Inc. (NYSE: TDOC), a leader in virtual healthcare services, has captured investor attention with its significant potential upside of 66.33%. Despite current challenges, the company represents a compelling..

Twist Bioscience Corporation (TWST) Stock Analysis: Unraveling the Growth Potential in Synthetic DNA

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a current market capitalization of $2.87 billion, Twist Bioscience is..

Omnicell, Inc. (OMCL) Stock Analysis: Investor Optimism Soars with 15.87% Potential Upside

Omnicell, Inc. (NASDAQ: OMCL) has been catching the attention of investors as it steadily positions itself as a key player in the healthcare sector, particularly within the health information services..

Catalyst Pharmaceuticals, Inc. (CPRX): Analyst Ratings Highlight 38% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is making waves in the biotechnology sector with a compelling growth narrative and an impressive analyst outlook. The company, based in Coral Gables, Florida, is..

Harmony Biosciences Holdings (HRMY) Stock Analysis: A Promising 22.77% Upside with Strong Buy Ratings

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its substantial potential upside of 22.77%, according to the latest analyst ratings. This Pennsylvania-based company, with..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A Potential 8.12% Upside Beckons Investors

Guardian Pharmacy Services, Inc. (GRDN) is catching the eye of investors with its robust performance and promising potential upside. As a key player in the healthcare sector, specifically within the..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech with 100% Potential Upside and Strong Buy Ratings

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology company, is creating ripples in the healthcare sector with its innovative approach to immunotherapy. As a commercial-stage company, Immunocore focuses on developing..

Evotec SE (EVO) Stock Analysis: Exploring a 63.93% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Evotec SE (EVO) an intriguing prospect. With a market capitalization of $1.21 billion, this German-based company is deeply embedded in the..

AtriCure, Inc. (ATRC) Stock Analysis: A Compelling 43% Upside Potential for Investors

For investors keen on the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents an intriguing opportunity. This Ohio-based company, with a market cap of $1.83 billion, specializes in developing and selling..

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Compelling 21.41% Potential Upside for Investors

Brookdale Senior Living Inc. (NYSE: BKD) stands as a formidable player within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Brentwood, Tennessee, this U.S.-based company has..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech Contender with a 108% Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN) has garnered significant attention in the biotechnology sector, offering a compelling opportunity for investors willing to navigate the high-risk, high-reward landscape of clinical-stage biotechs. With..

CG Oncology, Inc. (CGON) Stock Analysis: Biotechnology Innovator with a 45.78% Potential Upside

CG Oncology, Inc. (NASDAQ: CGON) is making waves in the biotechnology sector with its promising pipeline of therapeutics aimed at tackling bladder cancer. With a market capitalization of $4.49 billion,..

UFP Technologies, Inc. (UFPT) Stock Analysis: Healthcare Innovator with 28.78% Potential Upside

Investors keeping an eye on the medical devices sector may find UFP Technologies, Inc. (UFPT) to be an intriguing opportunity. With a market capitalization of $1.97 billion, this U.S.-based company..

Adaptive Biotechnologies (ADPT) Stock Analysis: Investor Outlook on a Healthcare Innovator with 102% Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands out in the biotechnology sector, not just for its innovative approach to immune medicine but also for its remarkable revenue growth of 102.40%. As..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds